According to the recent study the gene expression market is projected to grow at a CAGR of 7%-9% from 2020 to 2025. Growth in this market is primarily driven by decreasing cost of sequencing, technological advancements, rising prevalence of cancer, availability of government funding, novel technologies to aid gene expression studies, growing application areas of gene expression, and availability of gene expression databases.
Browse XX figures /
charts and XX tables in this 150 -page report to understand trends,
opportunities and forecast in gene expression market by product and service
(consumables (kits and reagents and DNA chips), instruments (PCR, NGS,
DNA microarray, and others), and services (gene expression profiling
services (sequencing services and other services) and bioinformatics
solutions), process (sample collection, purification, cDNA synthesis &
conversion, PCR analysis, and data analysis & interpretation), capacity
(low- to mid- plex and high-plex), technique (RNA expression (northern
blotting, DNA microarrays, PCR techniques, and RNA-seq), promoter analysis (in
vitro transcription/nuclear run-on assays, gel shift assays, and chromatin
immunoprecipitation (ChIP)), and protein expression & posttranslational
modification analysis (western blotting, 2-D gel electrophoresis, immunoassays,
and mass spectrometry), application (drug discovery & development, clinical
diagnostics, biotechnology & microbiology, and others), end user
(pharmaceutical and biotech companies, academic institutes and research
centers, and others), and region (North America, Europe, Asia Pacific, and Rest
of the World).
Download sample report
and view detailed Table of Content by clicking on below link https://www.lucintel.com/gene-expression-market.aspx
“Kits and reagents market is expected to
remain the largest segment during the forecast period.”
Based on product and
service, the gene expression market is segmented into kits and reagents and DNA
chips. Lucintel forecasts that the kits and reagents market is expected to remain
the largest segment due to the higher usage of these products, low price,
launch of novel kits and reagents with enhanced efficiency, and rising demand
for better data interpretation & visualization.
“Within the gene expression market, the pharmaceutical and
biotechnology companies segment is expected to remain the largest end user.”
Based on end user,the pharmaceutical
and biotechnology companies segment is expected to witness the highest growth
over the forecast period due to the utilization of gene expression analysis
products and services to achieve clinical research goals, increasing focus on
developing targeted therapies, and increasing in the demand for gene expression
analysis services offered by CROs.
“North America will dominate the gene expression market in near
future.”
North America will
remain the largest region, and it is also expected to witness the highest
growth over the forecast period due to the presence of a substantial number of
well-established players in the region, increased focus on advanced healthcare,
government support to initiatives that promote precision medicines, and high
investments in genomic research.
Download Brochure of this report by clicking on https://www.lucintel.com/gene-expression-market.aspx
Major players of gene
expression market are adopting various growth strategies like new product
launches, expansions, merger and acquisitions, partnerships, agreements, and
collaborations to expand their presence in this market. Illumina, Thermo Fisher
Scientific, Bio-Rad Laboratories, F. Hoffmann-La Roche, GE Healthcare, Pacific
Biosciences of California, Agilent Technologies, QIAGEN, Oxford Gene
Technologies, and Eurofins Scientific are among the major gene expression
providers.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or click on this link https://www.lucintel.com/gene-expression-market.aspxor helpdesk@lucintel.com.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market &unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times. For further information, visit www.lucintel.com.
Contact:
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751
Related reports
Minimally
Invasive Surgical Instrument Market:
For more details click here https://www.lucintel.com/minimally-invasive-surgical-instrument-market.aspx
Endoscopy
Equipment Market:
For more details click here https://www.lucintel.com/endoscopy-equipment-market.aspx
Surgical Instrument Tracking System Market:
For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx
Metabolomics Market:
For more details click here https://www.lucintel.com/metabolomics-market.aspx
Industrial Microbiology Market:
For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx
Surgical Microscope Market:
For more details click here https://www.lucintel.com/surgical-microscope-market.aspx
Tumor
Ablation Market:
For more details click here https://www.lucintel.com/tumor-ablation-market.aspx
Vitamin D Market:
For more details click here https://www.lucintel.com/vitamin-d-market.aspx
Urology
Device Market:
For more details click here https://www.lucintel.com/urology-device-market.aspx
GMO Testing Market:
For more details click here https://www.lucintel.com/gmo-testing-market.aspx
No comments:
Post a Comment